American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
- PMID: 12588714
- DOI: 10.1164/rccm.167.4.603
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
Comment in
-
Statements of ATS, CDC, and IDSA on treatment of tuberculosis.Am J Respir Crit Care Med. 2004 Jan 15;169(2):316-7; author reply 317. doi: 10.1164/ajrccm.169.2.952. Am J Respir Crit Care Med. 2004. PMID: 14718245 No abstract available.
Similar articles
-
Treatment of tuberculosis.MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77. MMWR Recomm Rep. 2003. PMID: 12836625 No abstract available.
-
[Comments on recent guidelines for the treatment of tuberculosis by the American Thoracic Society, the Centers for Disease Control and Prevention, and the Infectious Diseases Society of America].Arch Bronconeumol. 2003 Sep;39(9):379-81. doi: 10.1016/s0300-2896(03)75411-8. Arch Bronconeumol. 2003. PMID: 12975067 Spanish. No abstract available.
-
New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part.Am J Respir Crit Care Med. 2016 Oct 1;194(7):791-793. doi: 10.1164/rccm.201607-1419ED. Am J Respir Crit Care Med. 2016. PMID: 27556737 No abstract available.
-
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47. doi: 10.1164/ajrccm.161.supplement_3.ats600. Am J Respir Crit Care Med. 2000. PMID: 10764341 Review. No abstract available.
-
Treatment of tuberculosis.Am Fam Physician. 1991 Jul;44(1):219-24. Am Fam Physician. 1991. PMID: 2058533 Review.
Cited by
-
Isoniazid- and rifampicin-induced thrombocytopenia.Multidiscip Respir Med. 2013 Feb 13;8(1):13. doi: 10.1186/2049-6958-8-13. Multidiscip Respir Med. 2013. PMID: 23406847 Free PMC article.
-
Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.J Korean Med Sci. 2015 Feb;30(2):167-72. doi: 10.3346/jkms.2015.30.2.167. Epub 2015 Jan 21. J Korean Med Sci. 2015. PMID: 25653488 Free PMC article.
-
Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response.Korean J Intern Med. 2016 Jul;31(4):694-702. doi: 10.3904/kjim.2015.407. Epub 2016 Jun 3. Korean J Intern Med. 2016. PMID: 27271274 Free PMC article.
-
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.Antimicrob Agents Chemother. 2012 Jun;56(6):3232-8. doi: 10.1128/AAC.05526-11. Epub 2012 Mar 12. Antimicrob Agents Chemother. 2012. PMID: 22411614 Free PMC article.
-
Diversity of glpK Gene and Its Effect on Drug Sensitivity in Mycobacterium bovis.Infect Drug Resist. 2022 Apr 2;15:1467-1475. doi: 10.2147/IDR.S346724. eCollection 2022. Infect Drug Resist. 2022. PMID: 35401008 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical